| 000 | 01503 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517065921.0 | ||
| 264 | 0 | _c20160922 | |
| 008 | 201609s 0 0 eng d | ||
| 022 | _a1791-2423 | ||
| 024 | 7 |
_a10.3892/ijo.2015.3252 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaurin, Sebastien | |
| 245 | 0 | 0 |
_aA novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines. _h[electronic resource] |
| 260 |
_bInternational journal of oncology _cJan 2016 |
||
| 300 |
_a385-98 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCaspase 3 _xmetabolism |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aCurcumin _xadministration & dosage |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHuman Umbilical Vein Endothelial Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasm Invasiveness _xgenetics |
| 650 | 0 | 4 |
_aRaloxifene Hydrochloride _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Estrogen _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aNimick, Mhairi | |
| 700 | 1 | _aLarsen, Lesley | |
| 700 | 1 | _aRosengren, Rhonda J | |
| 773 | 0 |
_tInternational journal of oncology _gvol. 48 _gno. 1 _gp. 385-98 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3892/ijo.2015.3252 _zAvailable from publisher's website |
| 999 |
_c25524453 _d25524453 |
||